E19. Unpacking the Clinical Utility of Maternal TORCH Screening in Fetal Growth Restriction (video) Video
Talking O&G - a RANZCOG PodcastShow Notes
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks with Professor Lisa Hui and Associate Professor Natasha Holmes about the clinical utility of TORCH – Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) – serology in isolated fetal growth restriction (FGR). Professor Hui and A/Prof Holmes co-authored a study on this topic, considering whether TORCH serology should continue to be ordered for isolated FGR. They examine the importance of differentiating early- and late-onset FGR, how their findings reflect international screening recommendations, and whether TORCH screening can be a reassuring measure for patients. They highlight the waste of resources and potential increase of maternal anxiety associated with ordering TORCH serology in situations where it is clinically unnecessary. 🔗 Resources mentioned in this episode:
Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study
📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
More from Talking O&G - a RANZCOG Podcast
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks to gynaecologist Dr Catriona Melville and general practitioner Dr Anita Muñoz about RANZCOG’s binational clinical guideline Management of Vasomotor and Genitourinary Symptoms of Menopause. Dr Melville and Dr Muñoz speak on the scope of the guideline and how it can be used to support clinicians in assessment and treatment of vasomotor and genitourinary symptoms during menopause. They unpack the range of recommendations in the guideline, including menopausal hormone therapy (MHT) and non-hormonal therapies, and considerations such as when to begin and cease treatment, and treating women with a history of breast cancer. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks to gynaecologist Dr Catriona Melville and general practitioner Dr Anita Muñoz about RANZCOG’s binational clinical guideline Management of Vasomotor and Genitourinary Symptoms of Menopause. Dr Melville and Dr Muñoz speak on the scope of the guideline and how it can be used to support clinicians in assessment and treatment of vasomotor and genitourinary symptoms during menopause. They unpack the range of recommendations in the guideline, including menopausal hormone therapy (MHT) and non-hormonal therapies, and considerations such as when to begin and cease treatment, and treating women with a history of breast cancer. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Lucy Bowyer about the SOMANZ guidelines for the investigation and management of sepsis in pregnancy. Despite the overall maternal mortality rate declining in Australia, rates of maternal sepsis remain stable, and it is one of the most common causes of maternal deaths reported by the Australian Institute of Health and Welfare. A/Prof White and Dr Bowyer examine the statistics and why they have not declined alongside the overall maternal mortality rate. They explore the recommendations in the SOMANZ guideline and how they can be used to improve sepsis detection and treatment. Dr Bowyer provides actionable advice for clinicians regarding considerations such as anaesthesia, fetal surveillance, and antibiotics while breastfeeding. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Lucy Bowyer about the SOMANZ guidelines for the investigation and management of sepsis in pregnancy. Despite the overall maternal mortality rate declining in Australia, rates of maternal sepsis remain stable, and it is one of the most common causes of maternal deaths reported by the Australian Institute of Health and Welfare. A/Prof White and Dr Bowyer examine the statistics and why they have not declined alongside the overall maternal mortality rate. They explore the recommendations in the SOMANZ guideline and how they can be used to improve sepsis detection and treatment. Dr Bowyer provides actionable advice for clinicians regarding considerations such as anaesthesia, fetal surveillance, and antibiotics while breastfeeding. 🔗 Resources mentioned in this episode:
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks with Dr Rosie McBain, gynaecological oncologist, about cystic spaces in the endometrium on ultrasound and the correlation with endometrial hyperplasia or cancer. Dr McBain draws from the retrospective cohort study she conducted to examine this topic, the findings of which are published in ANZJOG. Dr Waterfall and Dr McBain discuss the findings of the study, its clinical implications, and areas that require further research. They address the nuances of clinical studies and the importance of patient-centred, individualised care. 🔗 Resources mentioned in this episode: